Scarica l'app Stockscreener
3.81
4.27%
-0.17
Perspective Therapeutics Inc Borsa (CATX) Ultime notizie
Perspective Therapeutics: Q2 Earnings Snapshot - Milford Mirror
Perspective Therapeutics Reports Q2 2025 Progress and Financials - TipRanks
Oppenheimer lowers Perspective Therapeutics stock price target to $14 - Investing.com India
Gain Therapeutics, Inc. shares rise 3.27% intraday after Perspective Therapeutics presented positive [212Pb]VMT-α-NET study update at ASCO Annual Meeting. - AInvest
Perspective Therapeutics: Navigating the Theranostics Frontier with Precision and Purpose - AInvest
Perspective Therapeutics Q2 Loss: $21.5M, Aligns with ForecastNews and Statistics - IndexBox
Perspective Therapeutics earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Perspective Therapeutics Reports Promising Study Results at ASCO - TipRanks
Perspective Therapeutics Inc (CATX) Q2 2025 Earnings: EPS Loss o - GuruFocus
Perspective Therapeutics Reports Q2 Loss - Nasdaq
Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 Results - The Globe and Mail
Perspective Therapeutics (CATX) posts Q2 2025 results and updated presentation | CATX SEC FilingForm 8-K - Stock Titan
Cancer Drug Developer Perspective Sees Treatment Success: 4 of 7 Patients Respond in Phase 1/2a Trial - Stock Titan
Perspective Therapeutics Q2 Earnings Preview: Analysts Expect Losses and Revenue Decline - AInvest
Can Perspective Therapeutics Inc. hit a new high this monthFree News Based Entry Opportunity Alerts - Newser
Multi factor analysis applied to Perspective Therapeutics Inc.Free Value Investing Picks With Stability - Newser
Perspective Therapeutics, Inc. shares rise 3.09% after-hours following a corporate update on clinical progress and strategic positioning. - AInvest
Published on: 2025-08-04 12:18:12 - Jammu Links News
When is Perspective Therapeutics Inc. stock expected to show significant growthInvest smarter with expert stock recommendations - Jammu Links News
Why is Perspective Therapeutics Inc. stock attracting strong analyst attentionConsistent triple returns - Jammu Links News
What are the technical indicators suggesting about Perspective Therapeutics Inc.Unlock your portfolio’s hidden potential - Jammu Links News
How does Perspective Therapeutics Inc. generate profit in a changing economyBuild wealth steadily with proven methods - Jammu Links News
What are the latest earnings results for Perspective Therapeutics Inc.Unlock rapid growth potential in your portfolio - Jammu Links News
How many analysts rate Perspective Therapeutics Inc. as a “Buy”Build a strong portfolio for long-term success - Jammu Links News
Perspective Therapeutics: Giving Us Some Valuable Perspective On Alpha Emitter Therapy - Seeking Alpha
Perspective Therapeutics (NYSE:CATX) vs. Motus GI (NASDAQ:MOTS) Critical Contrast - Defense World
How to read the order book for Perspective Therapeutics Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
Perspective Therapeutics Updates Radiopharmaceutical Platform Presentation - TipRanks
Live market analysis of Perspective Therapeutics Inc.Predictive AI Engine for Smart Investing - Newser
Applying chart zones and confluence areas to Perspective Therapeutics Inc.Short-Term AI-Based Stock Price Forecast - Newser
What makes Perspective Therapeutics Inc. stock price move sharplySwing Candidate List with Trade Cues - Newser
When is the best time to exit Perspective Therapeutics Inc.Smart Trade Mapping with Entry Details - Newser
How strong is Perspective Therapeutics Inc. company’s balance sheetTop Growth Tips For Consistent Profits - jammulinksnews.com
Perspective Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowAI Driven Buy Alert Trade Blueprint Released - metal.it
Volume spikes in Perspective Therapeutics Inc. stock – what they meanSector Rotation Outlook With Historical Summary - Newser
Is It Too Late to Sell Perspective Therapeutics Inc.Watchlist for Smart Swing Trading Updated - metal.it
Perspective Therapeutics shares fall 3.16% intraday after FDA approval conference call for Sephience. - AInvest
Is Perspective Therapeutics Inc. the Top Chart Pick This WeekCommunity Strategy With High Win Rate Backtested - metal.it
How volatile is Perspective Therapeutics Inc. stock compared to the marketFinancial News Outlook For 2025 - jammulinksnews.com
Is it the right time to buy Perspective Therapeutics Inc. stockAI Powered Target Finder For Consistent Profits - Jammu Links News
What is the dividend policy of Perspective Therapeutics Inc. stockStock Market Review That Work - Jammu Links News
Perspective Therapeutics shares fall 1.48% premarket after Unicycive Therapeutics receives FDA CRL. - AInvest
Volume spikes in Perspective Therapeutics Inc. stock – what they mean Asset Growth Pattern and Return Summary - Newser
What is the risk reward ratio of investing in Perspective Therapeutics Inc. stockInvest with confidence backed by data - Jammu Links News
0.31%
1.36%
Capitalizzazione:
|
Volume (24 ore):